Related Experiment Video
Updated: Feb 19, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Is adenosine associated with sudden death in schizophrenia? A new framework linking the adenosine pathway to risk of
Ary Gadelha1, André Zugman2, Mariana Bendlin Calzavara2
1Laboratório Interdisciplinar de Neurociências Clínicas (LINC), Departamento de Psiquiatria, Universidade Federal de São Paulo, Rua Pedro de Toledo, 669 , Vila Clementino, São Paulo, SP 04039-032, Brazil; Programa de Esquizofrenia da Universidade Federal de São Paulo (PROESQ), Departamento de Psiquiatria, Universidade Federal de São Paulo, Rua Machado Bittencourt, 222, Saúde, São Paulo 04044-000, Brazil.
Abstract:
Schizophrenia is associated with an increased mortality from cardiovascular disease. Relatively few studies have assessed the putative association of schizophrenia pathophysiology with sudden death. Low adenosine levels have been associated with schizophrenia. In cardiology, increased mortality among patients with congestive heart failure has been associated with genetic polymorphisms that potentially lead to lower adenosine levels. Thus, we hypothesize that adenosine could link schizophrenia and cardiovascular mortality, with decreased adenosine levels leading to increased vulnerability to hyperexcitability following hypoxic insults, increasing the odds of fatal arrhythmias. Low adenosine levels might also lead to a small increase in overall mortality rates and a major increase in the sudden death rate. This hypothesis paves the way for further investigation of the increased cardiac mortality associated with schizophrenia. Potentially, a better characterization of adenosine-related mechanisms of sudden death in schizophrenia could lead to new evidence of factors leading to sudden death in the general population.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
10:25Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
Published on: March 27, 2021
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Drug Toxicity: Risk factors
Coronary Artery Disease III: Clinical Manifestations